Interview with Jeff Bockman, PhD – Trends and Future Insights in the Immuno-Oncology Space
Oct 17, 2018
The interview provides insights into the dynamic space of Immuno-Oncology. To learn more, join BioNeex Webinar #2, in cooperation with Defined Health, a Cello Health business, on November 13th, 2018 - ''Trends and Future Insights in the Immuno-Oncology Space'' with Executive Vice President, Head of Oncology, Defined Health, Jeff Bockman, PhD. Don't miss this opportunity - register at https://bioneex.eventbrite.com For more information visit https://bioneex.com/news/ About the speaker: Dr. Bockman leads the Oncology and Virology Practices at Defined Health. The cancer practice is DH's largest therapeutic area. Before joining Defined Health, Dr. Bockman was a Senior Research Scientist and Research Project Leader in the commercial development of oligonucleotide therapeutics for viral diseases and cancer at Innovir Laboratories; and an Assistant Research Professor at the George Washington University School of Medicine. He received a BA from University of California at San Diego, and a PhD in Medical Microbiology from the University of California at Berkeley. He also earned an MA in English/Creative Writing from New York University. BioNeex is an online peer-to-peer platform facilitating licensing and collaborative partnerships in the biopharma industry. The platform supports the business development efforts of development-stage biopharma companies to display their novel compounds on a global scale by directly connecting them with potential licensing and co-development partners around the world. On the other hand, the platform is a unique opportunity for biopharma companies who want to expand their R&D pipeline by having direct access to such innovative compounds in development.